ADMA BIOLOGICS, INC. (ADMA) Operating cash flow 2016–2025
ADMA BIOLOGICS, INC. (ADMA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$50.4MFY2025 · since FY2016: -$18.3M → $50.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $50.4M | -57.5% |
| FY2024 | $118.7M | +1248.5% |
| FY2023 | $8.8M | +114.8% |
| FY2022 | -$59.5M | +47.0% |
| FY2021 | -$112.4M | -10.2% |
| FY2020 | -$102.0M | -33.9% |
| FY2019 | -$76.2M | -21.6% |
| FY2018 | -$62.7M | -68.2% |
| FY2017 | -$37.3M | -104.0% |
| FY2016 | -$18.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice